SHENZHEN, China , Jan. 3, 2025 /PRNewswire/ -- Shenzhen GRIT Biotechnology Co., Ltd.
, a leading company in cell therapy globally, today announced the appointment of Jie Jia , Ph.D., as Chief Operating Officer (COO), effective on the date of this press release.
Dr. Jia, Jie brings over 20 years of strategic leadership experience within the biopharmaceutical and healthcare industries, especially in managing complex projects, establishing new business operations, optimizing processes, and guiding critical decision-making initiatives. Prior to joining GRIT Bio as Chief Operating Officer, Dr.
Jia served as a senior executive at CARsgen Therapeutics, where he successfully transformed the company from a startup to a public entity by establishing and spearheading U.S. operations.
Before transitioning into the industry, Dr. Jia was an assistant professor at the Cleveland Clinic and Case Western Reserve University . Dr.
Jia holds a Bachelor of Science in Biochemistry from Sichuan University, a Ph.D. in Biochemistry and Molecular Biology from the Chinese Academy of Sciences, a Postdoctoral Fellow Certificate in Molecular Medicine from the Cleveland Clinic, and an MBA in Leadership and Digital Marketing from Youngstown State University .
"We are delighted to welcome Dr. Jia as GRIT Bio's Chief Operating Officer," said Dr. Liu, Yarong, Chairman and CEO of GRIT Bio, "His experience in leading biotech companies and developing markets and collaborations overseas aligns seamlessly with GRIT B.
